Adenovirus-mediated expression of UHRF1 reduces the radiosensitivity of cervical cancer HeLa cells to γ-irradiation

Acta Pharmacologica Sinica

Volumn 30, Issue 4, 2009, Pages 458-466

  Li, Xin Li ^a   Meng, Qing Hui ^b   Fan, Sai Jun ^a,b  

^a SOOCHOW UNIVERSITY   (China)

^b GEORGETOWN UNIVERSITY   (United States)

Author keywords

DNA repair; HeLa cells; Radiosensitivity; UHRF1; XRCC4

Indexed keywords

SMALL INTERFERING RNA; UBIQUITIN PROTEIN LIGASE; XRCC4 PROTEIN; CCAAT ENHANCER BINDING PROTEIN; DNA BINDING PROTEIN; UHRF1 PROTEIN, HUMAN; XRCC4 PROTEIN, HUMAN;

APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CELL CYCLE; CELL SURVIVAL; CLONOGENIC ASSAY; CONTROLLED STUDY; FLOW CYTOMETRY; GAMMA RADIATION; GENE SILENCING; GENE TRANSFER; GENETIC TRANSFECTION; HELA CELL; HUMAN; HUMAN CELL; PROTEIN EXPRESSION; RADIOSENSITIVITY; UTERINE CERVIX CANCER; WESTERN BLOTTING; ADENOVIRUS; DNA REPAIR; FEMALE; GENETICS; PHYSIOLOGY; RADIATION DOSE; RADIATION EXPOSURE; UTERINE CERVIX TUMOR;

ADENOVIRIDAE; APOPTOSIS; CCAAT-ENHANCER-BINDING PROTEINS; DNA REPAIR; DNA-BINDING PROTEINS; FEMALE; GAMMA RAYS; HELA CELLS; HUMANS; RADIATION TOLERANCE; UTERINE CERVICAL NEOPLASMS;

EID: 65249135841     PISSN: 16714083     EISSN: 17457254     Source Type: Journal    
DOI: 10.1038/aps.2009.18     Document Type: Article

References (20)

1. Liu SS, Leung RC, Chan KY, Chiu PM, Cheung AN, Tam KF, et al. p73 Expression is associated with the cellular radiosensitivity in cervical cancer afer radiotherapy. Clin Cancer Res 2004; 10: 3309-16.
2. Kim TJ, Lee JW, Song SY, Choi JJ, Choi CH, Kim BG, et al. Increased expression of pAKT is associated with radiation resistance in cervical cancer. Br J Cancer 2006; 94: 1678-82
3. Uno T, Isobe K, Yamamoto S, Kawata T, Ito H. Postoperative radiation therapy for carcinoma of the uterine cervix. Radiat Med 2006; 24: 91-7.
4. Fujimori A, Matsuda Y, Takemoto Y, Hashimoto Y, Kubo E, Araki R, et al. Cloning and mapping of Np95 gene which encodes a novel nuclear protein associated with cell proliferation. Mamm Genome 1998; 9: 1032-5.
5. Miura M, Watanabe H, Sasaki T, Tatsumi K, Muto M. Dynamic changes in subnuclear NP95 location during the cell cycle and its spatial relationship with DNA replication foci. Cell Struct Funct 2000; 25: 149-59.
6. Bonapace IM, Latella L, Papait R, Nicassio F, Sacco A, Muto M, et al. Np95 is regulated by E1A during mitotic reactivation of terminally diferentiated cells and is essential for S phase entry. J Cell Biol 2002; 157: 909-14.
7. Citerio E, Papait R, Nicassio F, Vecchi M, Gomiero P, Mantovani R, et al. Np95 is a histone-binding protein endowed with ubiquitin ligase activity. Mol Cell Biol 2004; 24: 2526-35.
8. Sakai A, Kikuchi Y, Muroi M, Masui T, Furihata C, Uchida E, et al. Overexpression of NP95 mRNA by tumor promoters in the promotion phase of a two-stage BALB/3T3 cell transformation assay. Biol Pharm Bull 2003; 26: 347-51.
9. Bostick M, Kim JK, Estève PO, Clark A, Pradhan S, Jacobsen SE. UHRF1 plays a role in maintaining DNA methylation in mammalian cells. Science 2007; 317: 1760-4.
10. Sharif J, Muto M, Takebayashi S, Suetake I, Iwamatsu A, Endo TA, et al. Te SR protein Np95 mediates epigenetic inheritance by recruiting Dnmt1 to methylated DNA. Nature 2007; 450: 908-12.
11. Muto M, Kanari Y, Kubo E, Takabe T, Kurihara T, Fujimori A, et al. Targeted disruption of Np95 gene renders murine embryonic stem cells hypersensitive to DNA damaging agents and DNA replication blocks. J Biol Chem 2002; 277: 34549-55.
12. Muto M, Fujimori A, Nenoi M, Daino K, Matsuda Y, Kuroiwa A, et al. Isolation and characterization of a novel human radio-susceptibility gene, NP95. Radiat Res 2006; 166: 723-33.
13. Bronner C, Achour M, Arima Y, Chataigneau T, Saya H, Schini-Kerth VB. Te UHRF family: oncogenes that are drugable targets for cancer therapy in the near future? Pharmacol Ter 2007; 115: 419-34.
14. Jiao Y, Ge CM, Meng Q, Cao JP, Tong J, Fan S. Adenovirus-mediated expression of Tob1 sensitizes breast cancer cells to ionizing radiation. Acta Pharmacol Sin 2007; 28: 1628-36.
15. Lieber MR. Pathological and physiological double-strand breaks: roles in cancer, aging and the immune system. Am J Pathol 1998; 153: 1323-32.
16. Shrivastav M, De Haro LP, Nickoloff JA. Regulation of DNA double-strand break repair pathway choice. Cell Res 2008; 18: 134-47.
17. Sakata K, Someya M, Matsumoto Y, Hareyama M. Ability to repair DNA double-strand breaks related to cancer susceptibility and radiosensitivity. Radiat Med 2007; 25: 433-8.
18. Frank KM, Sekiguchi JM, Seidl KJ, Swat W, Rathbun GA, Cheng HL, et al. Late embryonic lethality and impaired V(D)J recombination in mice lacking DNA ligase IV. Nature 1998; 396: 173-7.
19. Gao Y, Ferguson DO, Xie W, Manis JP, Sekiguchi J, Frank KM, et al. Interplay of p53 and DNA-repair protein XRCC4 in tumorigenesis, genomic stability and development. Nature 2000; 404: 823-5.
20. Jones KR, Gewirtz DA, Yannone SM, Zhou S, Schatz DG, Valerie K, et al. Radiosensitization of MDA-MB-231 breast tumor cells by adenovirus-mediated overexpression of a fragment of the XRCC4 protein. Mol Cancer Ter 2005; 4: 1541-7.